Samsung Medical Center
Samsung Medical Center, Seoul — a tertiary university hospital and MEDIWIN partner hospital under a formal patient-referral agreement.
A doctor reviews them and replies within 48 hours.
No fee for patients
You pay the hospital directly — MEDIWIN charges you nothing.
Our team meets prospective patients and partners in person at international events.
Наша команда лично встречается с потенциальными пациентами и партнёрами на международных мероприятиях.
Tim kami bertemu langsung dengan calon pasien dan mitra di berbagai acara internasional.
يلتقي فريقنا بالمرضى المحتملين والشركاء وجهاً لوجه في فعاليات دولية.
Манай баг олон улсын арга хэмжээнүүдэд эмчилгээ сонирхож буй хүмүүстэй болон түншүүдтэйгээ биечлэн уулздаг.
MEDIWIN Co., Ltd., a foreign-patient facilitator registered in Korea (Registration No. A-2022-01-01-4465), arranges it. MEDIWIN sends your records to the liver surgery and transplant teams at Asan Medical Center or Samsung Medical Center and obtains the hospital's written opinion and cost estimate before you travel. For a transplant, Korean law allows a foreign patient only a living-donor transplant from a close relative, and the relationship must be verified and approved through KONOS; MEDIWIN helps prepare these documents and arranges an interpreter and accommodation.
You pay the hospital directly. MEDIWIN has no offices or representatives outside Korea; coordinators answer from Seoul by WhatsApp or Telegram (+82 10 8864 3792) and by email (mediwinkorea@gmail.com).
In early 2025 Asan Medical Center became the first single institution in the world to perform 9,000 liver transplants — 7,502 of them living-donor procedures. It has completed more than 300 living-donor liver transplants every year since 2010, and now performs around 400 annually.
For comparison, that annual volume far exceeds Europe’s largest liver transplant centre. Volume matters in transplant surgery: outcomes correlate strongly with how often a team performs the operation.
Asan is also one of the few centres with an established programme in ABO-incompatible living-donor liver transplantation — where donor and recipient blood types do not match — with outcomes reported as comparable to blood-type compatible transplants. For a patient whose only available donor is a mismatched family member, that is the difference between having an option and not having one.
MEDIWIN holds a formal patient-referral agreement with Asan Medical Center and has coordinated liver cancer surgery and transplant cases there.
Hepatocellular carcinoma (HCC). The most common primary liver cancer, frequently arising in patients with hepatitis B or C or cirrhosis — the disease pattern Korean centres see in very high volume.
Liver resection. Removal of the tumour with preservation of functioning liver, including laparoscopic and robotic approaches where the tumour position allows.
Living-donor liver transplantation. A partial liver from a healthy donor, usually a family member. Korea performs this at a scale seen almost nowhere else, largely because deceased-donor organs are scarce.
Deceased-donor liver transplantation. Where a suitable organ is allocated.
Locoregional therapy. TACE, radiofrequency and microwave ablation for tumours not suitable for immediate resection.
Bile duct and metastatic liver cancer, including cholangiocarcinoma and colorectal liver metastases.
Liver cases are time-sensitive and document-heavy. What we handle:
— Translation of your diagnosis, CT or MRI imaging, biopsy results, AFP and liver function panels into the format the hospital requires
— Submission to the hepatobiliary surgery or transplant department for review
— If a transplant is being considered, coordination of the donor evaluation process and the documentation Korean law requires
— Written cost estimate and expected length of stay before you travel
— Professional interpretation at every consultation
— Discharge summary, immunosuppression guidance and remote follow-up after you return home
Start with a second opinion. Send your diagnosis and imaging and a specialist will review whether resection, ablation or transplant is realistic for your case — before you commit to travelling. Request a second opinion →
Living-donor liver transplantation is available to international patients, and this is what Korean centres do at the highest volume. It requires a willing, medically suitable donor — in practice almost always a family member — who must also travel and undergo evaluation. Deceased-donor organ allocation is governed by Korean national rules that prioritise domestic patients, so a living donor is the realistic pathway for most overseas patients.
Not necessarily. Asan Medical Center runs an established ABO-incompatible living-donor programme with reported outcomes comparable to blood-type compatible transplantation. Whether it is appropriate in a specific case is a decision for the transplant team after reviewing both patient and donor.
It can be. Assessments of resectability differ between centres, and a high-volume liver programme sometimes takes on cases another hospital declined. It can also confirm the original assessment. Either way you find out from your records, without travelling — that is what the second opinion service is for.
Considerably longer than for most treatments — donor evaluation, surgery and post-operative monitoring for both patient and donor. The hospital gives a minimum length of stay with the cost estimate. We will not guess at a figure before the transplant team has reviewed the case.
The hospital issues a written estimate after reviewing your records, and it varies considerably with the procedure and the length of admission. MEDIWIN adds no fees to your medical bill — you pay the hospital directly.
Important. MEDIWIN provides this service to patients residing outside Korea only. It is not offered to residents of Korea. MEDIWIN is a medical tourism facilitator, not a medical provider: every clinical opinion, diagnosis and treatment decision is made and issued by a licensed physician at the treating hospital. MEDIWIN translates and delivers your records to that hospital and delivers the hospital’s response back to you. It does not write, alter, summarise or interpret any medical opinion.
Related: how to apply to Asan Medical Center as an international patient, and what treatment in Korea actually costs.
Samsung Medical Center, Seoul — a tertiary university hospital and MEDIWIN partner hospital under a formal patient-referral agreement.
General hospital
General hospital
Women’s health, General hospital
A doctor reviews them and replies within 48 hours. Send what you already have — you don’t need every test.
No fee for patients
You pay the hospital directly — MEDIWIN charges you nothing.